Effects of an alpha1A/D‐adrenoceptor antagonist, naftopidil, and a phosphodiesterase type 5 inhibitor, tadalafil, on urinary bladder remodeling in rats with spinal cord …
K Kadekawa, T Majima, N Kawamorita… - Neurourology and …, 2017 - Wiley Online Library
Aims In order to clarify whether an alpha1A/D‐adrenoceptor (α1A/D‐AR) antagonist,
naftopidil, or a phosphodiesterase type 5 (PDE5) inhibitor, tadalafil, prevents bladder wall …
naftopidil, or a phosphodiesterase type 5 (PDE5) inhibitor, tadalafil, prevents bladder wall …
Effects of an alpha1A/D-adrenoceptor antagonist, naftopidil, and a phosphodiesterase type 5 inhibitor, tadalafil, on urinary bladder remodeling in rats with spinal cord …
K Kadekawa, T Majima… - Neurourology and …, 2017 - tohoku.elsevierpure.com
Aims: In order to clarify whether an alpha1A/D-adrenoceptor (α 1 A/D-AR) antagonist,
naftopidil, or a phosphodiesterase type 5 (PDE5) inhibitor, tadalafil, prevents bladder wall …
naftopidil, or a phosphodiesterase type 5 (PDE5) inhibitor, tadalafil, prevents bladder wall …
Effects of an alpha1A/D-adrenoceptor antagonist, naftopidil, and a phosphodiesterase type 5 inhibitor, tadalafil, on urinary bladder remodeling in rats with spinal cord …
K Kadekawa, T Majima… - Neurourology and …, 2017 - pubmed.ncbi.nlm.nih.gov
Aims In order to clarify whether an alpha1A/D-adrenoceptor (α 1 A/D-AR) antagonist,
naftopidil, or a phosphodiesterase type 5 (PDE5) inhibitor, tadalafil, prevents bladder wall …
naftopidil, or a phosphodiesterase type 5 (PDE5) inhibitor, tadalafil, prevents bladder wall …
[引用][C] Effects of an alpha1A/D-adrenoceptor antagonist, naftopidil, and a phosphodiesterase type 5 inhibitor, tadalafil, on urinary bladder remodeling in rats with spinal …
K Kadekawa, T Majima, N Kawamorita… - Neurourology and …, 2016 - cir.nii.ac.jp
Effects of an alpha1A/D-adrenoceptor antagonist, naftopidil, and a phosphodiesterase type 5
inhibitor, tadalafil, on urinary bladder remodeling in rats with spinal cord injury | CiNii Research …
inhibitor, tadalafil, on urinary bladder remodeling in rats with spinal cord injury | CiNii Research …
Effects of an alpha1A/D-adrenoceptor antagonist, naftopidil, and a phosphodiesterase type 5 inhibitor, tadalafil, on urinary bladder remodeling in rats with spinal cord …
K Kadekawa, T Majima, N Kawamorita… - Neurourology and …, 2016 - europepmc.org
Aims In order to clarify whether an alpha1A/D-adrenoceptor (α 1 A/D-AR) antagonist,
naftopidil, or a phosphodiesterase type 5 (PDE5) inhibitor, tadalafil, prevents bladder wall …
naftopidil, or a phosphodiesterase type 5 (PDE5) inhibitor, tadalafil, prevents bladder wall …